Literature DB >> 30661239

Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles.

Paola Nicoletti1,2, Guruprasad P Aithal3, Thomas C Chamberlain4,5, Sally Coulthard4, Mohammad Alshabeeb4,6, Jane I Grove3,7, Raul J Andrade8,9, Einar Bjornsson10, John F Dillon11, Par Hallberg12, M Isabel Lucena8,9, Anke H Maitland-van der Zee13, Jennifer H Martin14, Mariam Molokhia15, Munir Pirmohamed16, Mia Wadelius12, Yufeng Shen17,18, Matthew R Nelson19, Ann K Daly4.   

Abstract

Some patients prescribed flucloxacillin (~ 0.01%) develop drug-induced liver injury (DILI). HLA-B*57:01 is an established genetic risk factor for flucloxacillin DILI. To consolidate this finding, identify additional genetic factors, and assess relevance of risk factors for flucloxacillin DILI in relation to DILI due to other penicillins, we performed a genomewide association study involving 197 flucloxacillin DILI cases and 6,835 controls. We imputed single-nucleotide polymorphism and human leukocyte antigen (HLA) genotypes. HLA-B*57:01 was the major risk factor (allelic odds ratio (OR) = 36.62; P = 2.67 × 10-97 ). HLA-B*57:03 also showed an association (OR = 79.21; P = 1.2 × 10-6 ). Within the HLA-B protein sequence, imputation showed valine97 , common to HLA-B*57:01 and HLA-B*57:03, had the largest effect (OR = 38.1; P = 9.7 × 10-97 ). We found no HLA-B*57 association with DILI due to other isoxazolyl penicillins (n = 6) or amoxicillin (n = 15) and no significant non-HLA signals for any penicillin-related DILI.
© 2019 The Authors Clinical Pharmacology & Therapeutics © 2019 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30661239     DOI: 10.1002/cpt.1375

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  15 in total

Review 1.  An Approach to Drug-Induced Liver Injury from the Geriatric Perspective.

Authors:  Brian T Lee; Joseph A Odin; Priya Grewal
Journal:  Curr Gastroenterol Rep       Date:  2021-04-12

Review 2.  Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.

Authors:  Antonio Segovia-Zafra; Daniel E Di Zeo-Sánchez; Carlos López-Gómez; Zeus Pérez-Valdés; Eduardo García-Fuentes; Raúl J Andrade; M Isabel Lucena; Marina Villanueva-Paz
Journal:  Acta Pharm Sin B       Date:  2021-11-18       Impact factor: 11.413

3.  Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics.

Authors:  Ann M Moyer; Manish J Gandhi
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Roles of Cofactors in Drug-Induced Liver Injury: Drug Metabolism and Beyond.

Authors:  Ruizhi Gu; Alina Liang; Grace Liao; Isabelle To; Amina Shehu; Xiaochao Ma
Journal:  Drug Metab Dispos       Date:  2022-02-27       Impact factor: 3.579

Review 5.  What have we learned from animal models of idiosyncratic, drug-induced liver injury?

Authors:  Robert A Roth; Patricia E Ganey
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-05-04       Impact factor: 4.481

Review 6.  Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019.

Authors:  Rolf Teschke
Journal:  Front Pharmacol       Date:  2019-07-23       Impact factor: 5.810

7.  Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions.

Authors:  Paola Nicoletti; Sarah Barrett; Laurence McEvoy; Ann K Daly; Guruprasad Aithal; M Isabel Lucena; Raul J Andrade; Mia Wadelius; Pär Hallberg; Camilla Stephens; Einar S Bjornsson; Peter Friedmann; Kati Kainu; Tarja Laitinen; Anthony Marson; Mariam Molokhia; Elizabeth Phillips; Werner Pichler; Antonino Romano; Neil Shear; Graeme Sills; Luciana K Tanno; Ashley Swale; Aris Floratos; Yufeng Shen; Matthew R Nelson; Paul B Watkins; Mark J Daly; Andrew P Morris; Ana Alfirevic; Munir Pirmohamed
Journal:  Clin Pharmacol Ther       Date:  2019-07-03       Impact factor: 6.875

Review 8.  Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions.

Authors:  Chih-Jung Chang; Chun-Bing Chen; Shuen-Iu Hung; Chao Ji; Wen-Hung Chung
Journal:  Front Pharmacol       Date:  2020-07-02       Impact factor: 5.810

Review 9.  Pharmacogenomics of Antibiotics.

Authors:  Gabriele Stocco; Marianna Lucafò; Giuliana Decorti
Journal:  Int J Mol Sci       Date:  2020-08-19       Impact factor: 5.923

Review 10.  The toxicity of the methylimidazolium ionic liquids, with a focus on M8OI and hepatic effects.

Authors:  Alistair C Leitch; Tarek M Abdelghany; Philip M Probert; Michael P Dunn; Stephanie K Meyer; Jeremy M Palmer; Martin P Cooke; Lynsay I Blake; Katie Morse; Anna K Rosenmai; Agneta Oskarsson; Lucy Bates; Rodrigo S Figueiredo; Ibrahim Ibrahim; Colin Wilson; Noha F Abdelkader; David E Jones; Peter G Blain; Matthew C Wright
Journal:  Food Chem Toxicol       Date:  2019-12-27       Impact factor: 6.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.